Literature DB >> 2085635

Estimating integrals using quadrature methods with an application in pharmacokinetics.

A J Bailer1, W W Piegorsch.   

Abstract

The estimation of integrals using numerical quadrature is common in many biological studies. For instance, in biopharmaceutical research the area under curves is a useful quantity in deriving pharmacokinetic parameters and in providing a surrogate measure of the total dose of a compound at a particular site. In this paper, statistical issues as separate from numerical issues are considered in choosing a quadrature rule. The class of Newton-Côtes numerical quadrature procedures is examined from the perspective of minimizing mean squared error (MSE). The MSE are examined for a variety of functions commonly encountered in pharmacokinetics. It is seen that the simplest Newton-Côtes procedure, the trapezoidal rule, frequently provides minimum MSE for a variety of concentration-time shapes and under a variety of response variance conditions. A biopharmaceutical example is presented to illustrate these considerations.

Mesh:

Year:  1990        PMID: 2085635

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  4 in total

1.  Construction of an optimal destructive sampling design for noncompartmental AUC estimation.

Authors:  F Vandenhende; M Comblain; M H Delsemme; W Dewe; W P Hoffman; B Boulanger
Journal:  J Pharmacokinet Biopharm       Date:  1999-04

2.  Variability of the model-independent AUC: the one sample per individual case.

Authors:  W Jawień
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

3.  A note on testing areas under the curve when using destructive measurement techniques.

Authors:  H Heinzl
Journal:  J Pharmacokinet Biopharm       Date:  1996-12

4.  Weighted serum pools in comparison to the trapezoidal rule for estimating AUCs for ethinyl estradiol. The relationship of the variance of the determination to the interindividual variance.

Authors:  T Louton; W Kuhnz; L Dibbelt; R Knuppen
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.